Ligand Pharma's topical skin drug gets US FDA approval

Ligand Pharmaceuticals Incorporated

05/01/2024 21:35

Jan 5 (Reuters) - The U.S. Food and Drug Administration
approved Ligand Pharmaceuticals'  LGND.O  drug for the topical
treatment of a viral skin infection, the company said on Friday.
  

 (Reporting by Pratik Jain and Sriparna Roy in Bengaluru;
Editing by Tasim Zahid)
 ((Pratik.Jain@thomsonreuters.com;))